Label Snafu Has Bay Area’s Loard’s Yanking Ice Cream From Freezers
Loard’s voluntarily recalled dozens of 32oz and 56oz tubs after an FDA inspection found missing allergen labels. Return affected products for a refund or replacement.
Santa Clara Chip Titan Hit With $252 Million China Export Penalty
Applied Materials agreed to a $252.5M BIS settlement that forces audits and keeps export privileges on a three‑year leash. The ruling reshapes routing strategies for chip tools.
Westminster Lotto Slip Snags $600K As Fantasy 5 Nears $1M Statewide
Twelve California Fantasy 5 tickets paid $992,456 this week, topped by a $605,089 Westminster win. Here’s where the winning tickets were sold and how to claim.
Cupertino Power Shuffle: Apple Taps Hardware Chief John Ternus As Next CEO As Cook Moves Upstairs
Apple announced a planned leadership handoff: John Ternus will become CEO on Sept. 1, 2026, while Tim Cook moves to executive chairman and stays through the summer. The board approved the transition unanimously.
Deloitte Slashes Perks for Bay Area Back-Office Staff
Deloitte will cut PTO, halve paid parental leave and remove a $50,000 family‑building reimbursement for employees in its “Center” support model, effective Jan. 1, 2027. The move is part of a broader talent overhaul and has drawn worker pushback.
Meta’s Multi‑Gigawatt AI Power Play With Broadcom Supercharges Silicon Valley
Meta and Broadcom struck a multiyear partnership to co-develop MTIA accelerators, committing an initial deployment beyond 1GW and plotting a multi‑gigawatt rollout.
Bay Area EV Underdog Lucid Grabs Billion-Dollar Lifeline And New Boss
Lucid named Silvio Napoli as CEO and secured roughly $750M from the PIF and Uber while pricing a $300M offering as it pushes midsize models and robotaxis. The company reaffirmed 2026 production guidance but flagged heavy losses.
Mountain View Heartflow Cries 'Technological Piracy' In AI Heart Tech War With NY Rival
Heartflow sued Cleerly in federal court, alleging theft of AI-powered heart‑imaging patents and staff. The suit could reshape competition in noninvasive cardiac diagnostics.












